Douglas Flora: Oncology’s Next Chapter – AI is Turning the Page to Progress
Douglas Flora, Executive Medical Director of Oncology Services at St. Elizabeth Healthcare, shared a post on LinkedIn:
“Oncology’s Next Chapter: AI is Turning the Page to Progress
For those of you now getting curious after AI was everywhere at ASCO25, here a follow-up essay to help you imagine where all of this is headed. I discuss how it can help you in your hospital, practice, or daily lives.
Imagine a world where AI doesn’t replace oncologists, but helps it as Co-Pilot: augmenting our clinical wisdom and rehumanizing cancer care. It explores how AI can free clinicians from data overload and administrative burdens. It’s about restoring the art and soul of medicine.
Discover how AI acts as:
- The Information Navigator: Taming the ‘tsunami of data’ by synthesizing vast research and patient records.
- The Augmented Diagnostician: Providing a ‘second pair of eyes’ to catch subtle signals and uncover new patterns in medical imaging and pathology.
- The Personalized Therapy Strategist: Guiding complex treatment decisions to maximize outcomes and minimize toxicity.
‘The true promise of AI… may lie in its ability to foster a re-humanization of clinical practice, to restore and amplify the very elements of medicine that are most easily eroded by the pressures of the modern healthcare system.’
This isn’t about automation for automation’s sake; it’s about liberating oncologists to focus on what truly matters: deep critical thinking, empathetic connection, and individualized patient care.
Read the full essay to understand how AI can help transform cancer care for both patients and clinicians.”
More posts featuring Douglas Flora.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023